HEALTH OF WOMAN. 2017.8(124):21–26; doi 10.15574/HW.2017.124.21  

Tsubanova N. A., Sevastyanova T. V., Tsubanova E. S.
National Pharmaceutical University, Kharkiv
Kharkiv National University. V.N. Karazin

The article analyzes modern research on the functional activity of microbiota and its relationship to the state of human health. A detailed consideration of the role of dysbiosis in gynecological practice. Requirements for modern probiotic drugs are given. It is established that one of the drugs that meet modern criteria is the multi-probiotic probiotic Probiz Femina (Organosyn), for which a sufficient evidence base has been accumulated, which makes it an effective and safe probiotic for many cohorts of patients.
Key words: microbiota, dysbiosis, multi-probiotic probiotic Probiz Femina.

REFERENCES

1. Clemente JC, Ursell LK, Parfrey LW et al. 2012. The Impact of the Gut Microbiota on Human health: An Integrative Viev. Cell. 148:1258–1270. https://doi.org/10.1016/j.cell.2012.01.035; PMid:22424233 PMCid:PMC5050011

2. Robinson CJ, Bohannan BJ, Young VB. 2010. From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev. 74:453–476. https://doi.org/10.1128/MMBR.00014-10; PMid:20805407 PMCid:PMC2937523

3. Robinson CJ, Bohannan BJ, Young VB. 2010. From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev. 74:453–476. https://doi.org/10.1128/MMBR.00014-10; PMid:20805407 PMCid:PMC2937523

4. Ganal-Vonarburg SC, Fuhrer T, Gomez de Agüero M. 2017. Maternal microbiota and antibodies as advocates of neonatal health. Gut Microbes. 3:1–7. https://doi.org/10.1080/19490976.2017.1299847

5. Koenig JE, Spor A, Scalfone N et al. 2011. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA. 108(Suppl. 1):4578–4585. https://doi.org/10.1073/pnas.1000081107; PMid:20668239 PMCid:PMC3063592

6. Dominguez-Bello MG, Costello EK, Contreras M et al. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA. 107:11971–11975. https://doi.org/10.1073/pnas.1002601107; PMid:20566857 PMCid:PMC2900693

7. Ley RE. 2010. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26:5–11. https://doi.org/10.1097/MOG.0b013e328333d751; PMid:19901833

8. Zhang H, DiBaise JK, Zuccolo A et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA. 106:2365–2370. https://doi.org/10.1073/pnas.0812600106; PMid:19164560 PMCid:PMC2629490

9. Vijay-Kumar M, Aitken JD, Carvalho FA et al. 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228–231. https://doi.org/10.1126/science.1179721; PMid:20203013 PMCid:PMC4714868

10. Cucchiara S. 2017, March 10.  Baby microbiome management. I International Summit dedicated to the problems of microbiota. Paris: 2.

11. Vaishampayan PA, Kuehl JV, Froula JL et al. 2010. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biol. Evol. 2:53–66. https://doi.org/10.1093/gbe/evp057; PMid:20333224 PMCid:PMC2839348

12. Hsiao EY, McBride SW, Hsien S. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 155(7):1451–1463. https://doi.org/10.1016/j.cell.2013.11.024; PMid:24315484 PMCid:PMC3897394

13. Dore J. 2017, March 10. Factors affecting the microbiota. I International Summit dedicated to the problems of microbiota. Paris: 1.

14. Goldenberg JZ, Ma SS, Saxton JD et al. 2013. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 5:246–234. https://doi.org/10.1002/14651858.CD006095.pub3

15. Konturek PC, Koziel J, Dieterich W et al. 2016. Successful therapy of Clostridium difficile infection with fecal Microbiotajxansplantation. J Physiol Pharmacol. 67(6):859–866. PMid:28195066

16. Morreli L. 2017, March 10. The role of qualitative composition of probiotics in vitro and in vivo. I International Summit dedicated to the problems of microbiota. Paris: 6.

17. Polanco AI. 2015. Microbiota and gastrointestinal diseases. An Pediatr (Barc). 83(6):el-5. https://doi.org/10.1016/j.anpede.2015.11.003

18. Tuday VN, Limanskaya AYu, Mokrik AN i dr. 2015. Osobennosti mestnogo immuniteta i mikrobiotsinoza vlagalischa u beremennyih s sindromom razdrazhennogo kishechnika. Zdorove zhenschiny 4(100):1–3.

19. Kaminskiy VV, Konoplyanko VV, Vorobey LI i dr. 2014. Effektivnost peroralnyih probiotikov dlya vosstanovleniya vaginalnoy floryi. Zdorove zhenschinyi 6(92):2–6.

20. Goryanoy VA. 2016. Optimizatsiya lecheniya sheyki matki. Iskusstvo lechit 2(68):2–3.

21. Davydova YuV, Lymanska AIu, Mokryk OM ta in.Udoskonalennia likuvannia syndromu podraznenoho kyshechnyka u vahitnykh. Infrmatsiinyi lyst MOZ Ukrainy № 125 – 2016 vid 12.05.2016 r.